Coala Life Q2: Our comments - Redeye

Redeye comments on Coala Life’s Q2’22 report and the acquisition of Vitrics. We continue to expect a commercial ramp-up throughout 2022, given the indications of product-market fit in the U.S. The fundamentals are there for the market to continue to grow, and Coala-Life is well-positioned to leverage on this opportunity.

Länk till analysen i sin helhet: https://www.redeye.se/research/851895/coala-life-q222-our-comments?utm_source=finwire&utm_medium=RSS